R&D Changing how the world finds new medicines: Physics modellin... Finding treatments for diseases afflicting humanity often proceeds at a crawl, leaving many serious medical needs unmet.
Partner Content Partner Content Exclusive insights into the latest innovations at Drug Disco... Exclusive insights into the latest innovations
Partner Content Partner Content Invite from Roderick Hubbard, Vernalis Research chairing SMi... Invitation from Roderick E. Hubbard at DDC
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.